109 related articles for article (PubMed ID: 20377666)
1. Immunomodulation for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2010 Feb; (166):59-63. PubMed ID: 20377666
[TBL] [Abstract][Full Text] [Related]
2. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
3. Prediction and prevention of type 1 diabetes: progress, problems, and prospects.
Skyler JS
Clin Pharmacol Ther; 2007 May; 81(5):768-71. PubMed ID: 17392722
[TBL] [Abstract][Full Text] [Related]
4. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
5. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
6. [Immunological intervention to preserve beta-cell function in type 1 diabetes].
Schloot NC
Dtsch Med Wochenschr; 2010 May; 135(18):915-21. PubMed ID: 20425677
[TBL] [Abstract][Full Text] [Related]
7. The role of immunotherapy in type I diabetes mellitus.
Geffner ME; Lippe BM
West J Med; 1987 Mar; 146(3):337-43. PubMed ID: 3554759
[TBL] [Abstract][Full Text] [Related]
8. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy.
Sebastiani G; Vendrame F; Dotta F
Transplant Proc; 2011; 43(1):330-2. PubMed ID: 21335216
[TBL] [Abstract][Full Text] [Related]
10. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
11. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
[TBL] [Abstract][Full Text] [Related]
12. Preservation of beta-cell function during immune-mediated, B7-1-dependent alpha-cell destruction.
Skak K; Haase C; Michelsen BK
Eur J Immunol; 2005 Sep; 35(9):2583-90. PubMed ID: 16078275
[TBL] [Abstract][Full Text] [Related]
13. Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Verh K Acad Geneeskd Belg; 2008; 70(2):85-103. PubMed ID: 18630722
[TBL] [Abstract][Full Text] [Related]
14. [Is prevention of diabetes mellitus possible?].
Lehmann R; Spinas GA
Ther Umsch; 1994 Oct; 51(10):693-700. PubMed ID: 7839327
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the age-at-onset heterogeneity in type 1 diabetes through mathematical modeling.
Wang X; He Z; Ghosh S
Math Biosci; 2006 Sep; 203(1):79-99. PubMed ID: 16723139
[TBL] [Abstract][Full Text] [Related]
16. Rehabilitation of adaptive immunity and regeneration of beta cells.
Pasquali L; Fan Y; Trucco M; Ringquist S
Trends Biotechnol; 2006 Nov; 24(11):516-22. PubMed ID: 16963140
[TBL] [Abstract][Full Text] [Related]
17. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
18. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
19. The possibility that pancreatic beta cell destruction leading to type 1 diabetes is initiated by the release of cytokines by polyclonal activation of the immune system.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1990 Feb; 95(1):110-8. PubMed ID: 2139848
[TBL] [Abstract][Full Text] [Related]
20. [New findings on the pathogenesis of diabetes mellitus].
Keller U
Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
